Featured Research

from universities, journals, and other organizations

Zinc Therapy Accelerates Recovery From Pneumonia

Date:
May 21, 2004
Source:
Johns Hopkins University Bloomberg School Of Public Health
Summary:
Treating young children with zinc in addition to standard antibiotics greatly reduces the duration of severe pneumonia, according to a study by researchers from the Johns Hopkins Bloomberg School of Public Health and the International Centre for Diarrhoeal Disease Research, Bangladesh, Centre for Health and Population Research.

Treating young children with zinc in addition to standard antibiotics greatly reduces the duration of severe pneumonia, according to a study by researchers from the Johns Hopkins Bloomberg School of Public Health and the International Centre for Diarrhoeal Disease Research, Bangladesh, Centre for Health and Population Research (ICDDR, B). Pneumonia is a leading cause of illness and death among children under age 5, particularly in the developing world. The researchers believe zinc therapy could help reduce antimicrobial resistance by decreasing the exposure to multiple antibiotics and lessen the health complications and deaths worldwide caused by severe pneumonia. The study appears in the May 22, 2004, edition of The Lancet.

Related Articles


"Our study shows that adding zinc to the standard antibiotic treatment significantly reduces the recovery time and overall hospital stay of children with severe pneumonia," said lead author W. Abdullah Brooks, MD, MPH, an assistant scientist in the Bloomberg School's Department of International Health and a researcher with the ICDDR, B. "The children who received zinc were also less likely to need a change in the antibiotic being used. This could have significant implications for reducing antibiotic-resistant infections by decreasing antibiotic exposure," he said.

Dr. Brooks and his colleagues conducted a double-blinded, placebo-controlled trial with 270 children who were being treated for severe pneumonia at a hospital in Bangladesh. The children, all aged 2 months to 23 months, were randomly selected to receive either a 20mg dose of zinc daily or a placebo in addition to the standard antibiotic treatment for pneumonia.

The results showed that of the children who received zinc had a shorter duration of severe pneumonia symptoms and signs compared to children who received the placebo. These included indrawing of the chest when breathing, severely raised respiration rates and low oxygen concentration in the blood. Zinc therapy also reduced the duration of severe pneumonia and overall hospital stay by an average of one day. However, the zinc did not affect the overall length of hospital stay or the duration of severe pneumonia of children with wheezing. Only two children in the study's zinc group had failure of treatment with the initial standard antibiotics compared to 11 in the placebo group.

"The zinc supplement was safe and substantially reduced the effects of acute pneumonia in young children. It could be especially beneficial in the developing world where millions of children die from pneumonia each year and where second line antibiotics may not be available," said senior investigator, Robert Black, MD, professor and chair of the Department of International Health at the Johns Hopkins Bloomberg School of Public Health.

###

The authors of "Zinc for severe pneumonia in very young children: double-blind placebo-controlled trial" include, W.A. Brooks, M. Yunus, M.A. Wahed, K. Nahar and S. Yeasmin of the International Centre for Diarrhoeal Disease Research, Bangladesh, Centre for Health and Population Research. W.A. Brooks, M. Santosham and R. Black are with Department of International Health at the Johns Hopkins Bloomberg School of Public Health.

The study was funded by the Johns Hopkins Family Health and Child Survival Cooperative Agreement with the United Stated Agency for International Development and the International Centre for Diarrhoeal Disease Research, Bangladesh, Centre for Health and Population Research

For the latest public health news or to receive news releases from the Johns Hopkins Bloomberg School of Public Health via email, visit http://www.jhsph.edu/Press_Room.

For information on the International Centre for Diarrhoeal Disease Research, Bangladesh, Centre for Health and Population Research, visit http://www.icddrb.org.


Story Source:

The above story is based on materials provided by Johns Hopkins University Bloomberg School Of Public Health. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins University Bloomberg School Of Public Health. "Zinc Therapy Accelerates Recovery From Pneumonia." ScienceDaily. ScienceDaily, 21 May 2004. <www.sciencedaily.com/releases/2004/05/040521072802.htm>.
Johns Hopkins University Bloomberg School Of Public Health. (2004, May 21). Zinc Therapy Accelerates Recovery From Pneumonia. ScienceDaily. Retrieved October 30, 2014 from www.sciencedaily.com/releases/2004/05/040521072802.htm
Johns Hopkins University Bloomberg School Of Public Health. "Zinc Therapy Accelerates Recovery From Pneumonia." ScienceDaily. www.sciencedaily.com/releases/2004/05/040521072802.htm (accessed October 30, 2014).

Share This



More Health & Medicine News

Thursday, October 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Reuters - Innovations Video Online (Oct. 29, 2014) A Swedish amputee who became the first person to ever receive a brain controlled prosthetic arm is able to manipulate and handle delicate objects with an unprecedented level of dexterity. The device is connected directly to his bone, nerves and muscles, giving him the ability to control it with his thoughts. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Google To Use Nanoparticles, Wearables To Detect Disease

Google To Use Nanoparticles, Wearables To Detect Disease

Newsy (Oct. 29, 2014) Google X wants to improve modern medicine with nanoparticles and a wearable device. It's all an attempt to tackle disease detection and prevention. Video provided by Newsy
Powered by NewsLook.com
Can Drinking Milk Lead To Early Death?

Can Drinking Milk Lead To Early Death?

Newsy (Oct. 29, 2014) Researchers in Sweden released a study showing heavy milk drinkers face an increased mortality risk from a variety of causes. Video provided by Newsy
Powered by NewsLook.com
Obama: The US Will Not 'run and Hide' From Ebola

Obama: The US Will Not 'run and Hide' From Ebola

AP (Oct. 29, 2014) Surrounded by health care workers in the White House East Room, President Barack Obama said the U.S. will likely see additional Ebola cases in the weeks ahead. But he said the nation can't seal itself off in the fight against the disease. (Oct. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins